Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial

  1. Balmaña, J.
  2. Cruz, C.
  3. Arun, B.K.
  4. Telli, M.
  5. Garber, J.
  6. Domchek, S.
  7. Fernandez, C.M.
  8. Kahatt, C.
  9. Szyldergemajn, S.
  10. Soto-Matos, A.
  11. Haza, A.P.
  12. Fidalgo, J.A.P.
  13. Lluch-Hernandez, A.
  14. Antolin, S.
  15. Tung, N.M.
  16. Vahdat, L.T.
  17. Lopez, R.
  18. Isakoff, S.J.J.
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2016

Volumen: 27

Pages: vi68

Type: Article

DOI: 10.1093/ANNONC/MDW365.02 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus